Literature DB >> 17194620

Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay.

G Bailliet1, M R Santos, E L Alfaro, J E Dipierri, D A Demarchi, F R Carnese, N O Bianchi.   

Abstract

Interethnic differences in the allele frequencies of CYP2D6, NAT2, GSTM1 and GSTT1 deletions have been documented for Caucasians, Asians, and Africans population. On the other hand, data on Amerindians are scanty and limited to a few populations from southern areas of South America. In this report we analyze the frequencies of 11 allele variants of CYP2D6 and 4 allele variants of NAT2 genes, and the frequency of GSTM1 and GSTT1 homozygous deleted genotypes in a sample of 90 donors representing 8 Native American populations from Argentina and Paraguay, identified as Amerindians on the basis of their geographic location, genealogical data, mitochondrial- and Y-chromosome DNA markers. For CYP2D6, 88.6% of the total allele frequency corresponded to *1, *2, *4 and *10 variants. Average frequencies for NAT2 *4, *5, *6 and *7 alleles were 51.2%, 25%, 6.1%, and 20.1%, respectively. GSTM1 deletion ranged from 20% to 66%, while GSTT1 deletion was present in four populations in less than 50%. We assume that CYP2D6 *2, *4, *10, *14; NAT2 *5, *7 alleles and GSTM1 and GSTT1 *0/*0 genotypes are founder variants brought to America by the first Asian settlers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194620     DOI: 10.1016/j.mrgentox.2006.11.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals.

Authors:  Karina Cordero; Iris Espinoza; Dante Caceres; Angela Roco; Carla Miranda; Valentina Squicciarini; Paula Santander; Kuen Lee; Iván Saavedra; Luis Quiñones
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

2.  Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.

Authors:  Alison Fohner; LeeAnna I Muzquiz; Melissa A Austin; Andrea Gaedigk; Adam Gordon; Timothy Thornton; Mark J Rieder; Mark A Pershouse; Elizabeth A Putnam; Kevin Howlett; Patrick Beatty; Kenneth E Thummel; Erica L Woodahl
Journal:  Pharmacogenet Genomics       Date:  2013-08       Impact factor: 2.089

3.  Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil.

Authors:  L G Possuelo; J A Castelan; T C de Brito; A W Ribeiro; P I Cafrune; P D Picon; A R Santos; R L F Teixeira; T S Gregianini; M H Hutz; M L R Rossetti; A Zaha
Journal:  Eur J Clin Pharmacol       Date:  2008-04-18       Impact factor: 2.953

4.  Cigarette smoking, dietary habits and genetic polymorphisms in GSTT1, GSTM1 and CYP1A1 metabolic genes: A case-control study in oncohematological diseases.

Authors:  María Belén Cerliani; Walter Pavicic; Juan Antonio Gili; Graciela Klein; Silvia Saba; Silvina Richard
Journal:  World J Clin Oncol       Date:  2016-10-10

Review 5.  The Metabolization Profile of the CYP2D6 Gene in Amerindian Populations: A Review.

Authors:  Luciana P C Leitão; Tatiane P Souza; Juliana C G Rodrigues; Marianne R Fernandes; Sidney Santos; Ney P C Santos
Journal:  Genes (Basel)       Date:  2020-02-28       Impact factor: 4.096

6.  NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast region.

Authors:  Isis Arias; Nelly Lecompte; Lila Visbal; Iliana Curiel; Enio Hernández; Pilar Garavito; Carlos Silvera-Redondo
Journal:  Colomb Med (Cali)       Date:  2014-12-30

7.  CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6 (*) 15 and (*) 35 Genotyping.

Authors:  Amanda K Riffel; Mehdi Dehghani; Toinette Hartshorne; Kristen C Floyd; J Steven Leeder; Kevin P Rosenblatt; Andrea Gaedigk
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.